18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma.
about
Transcatheter embolization therapy in liver cancer: an update of clinical evidences[18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantationThe prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer.Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular CarcinomaPrognostic Value of Tumor-to-Blood Standardized Uptake Ratio in Patients with Resectable Non-Small-Cell Lung Cancer.Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.Diagnostic accuracy of (18) F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
P2860
Q27003849-AB3F12D3-7F15-4762-9287-82BF043842D3Q27691331-2E249C97-F40C-49CF-AE79-9F575BF3BCB3Q33594891-D31A906E-D0E7-4131-B0D9-089DBE042FF3Q33686817-F9844879-6390-4A4B-A9B6-EE2B6F4132E1Q36195043-69AEC047-D08A-44AB-AA15-0E3FD9E81D6EQ38416627-4D2690E2-71AE-4970-BF39-538476803B6BQ41706815-C3EB649C-0BDB-46EF-9868-EF32F99F887BQ50211377-D72C27E3-E584-4CE5-ADB6-8C671E0BBFECQ52988390-66C1EA94-50C3-4E43-90ED-C28E7BA92F37Q53027673-717C2251-31AB-4F69-BAA1-2261AFB7269DQ53111789-13E2F5ED-68EB-4E2D-B0D5-749191CCA016Q57153750-042FC265-2A53-4929-AA99-3045B69541A0Q58739392-6B775FE6-597F-4217-AB36-9433D15EC929
P2860
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
18F-fluorodeoxyglucose PET/CT ...... n in hepatocellular carcinoma.
@en
18F-fluorodeoxyglucose PET/CT ...... n in hepatocellular carcinoma.
@nl
type
label
18F-fluorodeoxyglucose PET/CT ...... n in hepatocellular carcinoma.
@en
18F-fluorodeoxyglucose PET/CT ...... n in hepatocellular carcinoma.
@nl
prefLabel
18F-fluorodeoxyglucose PET/CT ...... n in hepatocellular carcinoma.
@en
18F-fluorodeoxyglucose PET/CT ...... n in hepatocellular carcinoma.
@nl
P2093
P2860
P1476
18F-fluorodeoxyglucose PET/CT ...... n in hepatocellular carcinoma.
@en
P2093
Do Sun Song
Hae Giu Lee
Hee Yeon Kim
Ho Jong Chun
Ie Ryung Yoo
Jong Young Choi
Myeong Jun Song
Seung Kew Yoon
Si Hyun Bae
Sung Won Lee
P2860
P2888
P304
P356
10.1007/S00259-013-2366-2
P50
P577
2013-02-22T00:00:00Z